RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Myriad Genetics Incorporated

A collection of news and information related to Myriad Genetics Incorporated published by this site and its partners.

Top Myriad Genetics Incorporated Articles see all

Displaying items 1-5
  • The human cost of our flawed experiment with gene patents

    Nina, a resident of East Baltimore, celebrated her 41st birthday last Sunday. Surrounded by family and friends, she struggled for breath to extinguish the candles on her cake. Two years ago Nina was diagnosed with breast cancer. Genetic testing and prophylaxis might have prevented her illness, but unlike actress Angela Jolie, her financial resources did not allow her to take the $3,400 test. Now Nina suffers from the same disease that took the life of her mother when she was in her 40s, and her older sister, who died at the age of 34 from breast and ovarian cancer. With 11 chemotherapy infusions and two blood transfusions behind her, this wife and mother of two young daughters faces formidable odds. This is the sad result of a biomedical Wild West marketplace fiercely competing for the promise that genomic advances hold for the discovery and development of new therapies.
  • Ban on patenting DNA cheers researchers

    Ban on patenting DNA cheers researchers
    Researchers hailed the Supreme Court ruling Wednesday that bans the patenting of human DNA, saying it would expand access to genetic testing for disease at lower cost to patients. In a unanimous decision, the justices said Myriad Genetics did not have...

    The red herring of human gene patents

    The red herring of human gene patents
    The greatest dangers to liberty lurk in the insidious encroachment by men of zeal, well meaning but without understanding. — Louis D. Brandeis Just a few words and little thought separate yet another stronghold of the American economy from ruin....

    Gene patent case could impact patients, research

    Gene patent case could impact patients, research
    Every time a woman is tested for gene mutations linked to significantly higher rates of breast and ovarian cancer, her blood is sent to a lab in Utah. That's because Salt Lake City-based Myriad Genetics Inc. owns the patents to the BRCA 1 and BRCA 2...

    ACLU asks Supreme Court to reconsider gene patenting case

    ACLU asks Supreme Court to reconsider gene patenting case
    The American Civil Liberties Union has asked for a second time that the Supreme Court invalidate Myriad Genetics Inc.'s patents on two genes associated with hereditary breast and ovarian cancers, the latest salvo in a case with broad consequences for...